Response of the erythron and erythropoietin to autologous blood donations in paediatric subjects. Is erythropoietin supplement necessary?

被引:7
作者
Han, P
Stacy, D
机构
[1] Department of Haematology, Women's and Children's Hospital, North Adelaide, SA
[2] Department of Haematology, Women's and Children's Hospital, North Adelaide, SA 5006
关键词
D O I
10.1046/j.1423-0410.1997.7310024.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives: This study was undertaken to evaluate the need for erythropoietin (Epo) therapy to augment autologous blood collection in adolescents undergoing spinal corrective surgery. Methods: We measured serum Epo and parameters of iron metabolism in 35 adolescents undergoing autologous blood collection for orthopaedic surgery. Ages of subjects ranged from 11 to 16 years (mean 15.5 years) with a female predominance. Generally, 10% of intravascular blood volume was collected once a week up to a total of three collections. Results: There was an average 2.5-fold rise in serum Epo over the period of blood collection. Epo increased immediately after blood collection. There was a 1.4-fold rise in reticulocyte count, consistent with the Epo response, and an average of 1.5 units of red blood cells (200 ml, unit) being produced over this period, Despite this there was an average fall of 2 g/dl (15%) in haemoglobin level, Serum ferritin and transferrin saturation also fell. Conclusions: Paediatric subjects: are able to donate the required units of blood as they have a good Epo response to mild anaemia. The amount of blood donated did not exceed their total mobilisable iron and the iron supplement was adequate for red cell synthesis.
引用
收藏
页码:24 / 27
页数:4
相关论文
共 14 条
[1]
ANDERSON KC, 1990, NEW ENGL J MED, V323, P315
[2]
THE EFFECT OF ORAL IRON SUPPLEMENTATION ON ERYTHROPOIESIS IN AUTOLOGOUS BLOOD-DONORS [J].
BIESMA, DH ;
KRAAIJENHAGEN, RJ ;
POORTMAN, J ;
MARX, JJM ;
VANDEWIEL, A .
TRANSFUSION, 1992, 32 (02) :162-165
[3]
BRENNAN MT, 1993, CURR OPINION HEMATOL, V2, P320
[4]
CLAAS FHJ, 1981, EXP HEMATOL, V9, P84
[5]
COOK JD, 1986, BLOOD, V68, P726
[6]
A PHASE-III TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN NONANEMIC ORTHOPEDIC PATIENTS SUBJECTED TO AGGRESSIVE REMOVAL OF BLOOD FOR AUTOLOGOUS USE - DOSE, RESPONSE, TOXICITY, AND EFFICACY [J].
GOODNOUGH, LT ;
PRICE, TH ;
FRIEDMAN, KD ;
JOHNSTON, M ;
CIAVARELLA, D ;
KHAN, N ;
SACHER, R ;
VOGLER, WR ;
WISSEL, M ;
ABELS, RI .
TRANSFUSION, 1994, 34 (01) :66-71
[7]
GOODNOUGH LT, 1989, ARCH SURG-CHICAGO, V124, P494
[8]
PREOPERATIVE RED-CELL PRODUCTION IN PATIENTS UNDERGOING AGGRESSIVE AUTOLOGOUS BLOOD PHLEBOTOMY WITH AND WITHOUT ERYTHROPOIETIN THERAPY [J].
GOODNOUGH, LT ;
PRICE, TH ;
RUDNICK, S ;
SOEGIARSO, RW .
TRANSFUSION, 1992, 32 (05) :441-445
[9]
INCREASED PREOPERATIVE COLLECTION OF AUTOLOGOUS BLOOD WITH RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY [J].
GOODNOUGH, LT ;
RUDNICK, S ;
PRICE, TH ;
BALLAS, SK ;
COLLINS, ML ;
CROWLEY, JP ;
KOSMIN, M ;
KRUSKALL, MS ;
LENES, BA ;
MENITOVE, JE ;
SILBERSTEIN, LE ;
SMITH, KJ ;
WALLAS, CH ;
ABELS, R ;
VONTRESS, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1163-1168
[10]
EFFECT OF REPEATED WHOLE-BLOOD DONATIONS ON SERUM IMMUNOREACTIVE ERYTHROPOIETIN LEVELS IN AUTOLOGOUS DONORS [J].
KICKLER, TS ;
SPIVAK, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (01) :65-67